Literature DB >> 12560281

Pathogenesis of sepsis: new concepts and implications for future treatment.

Pierre-Yves Bochud1, Thierry Calandra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12560281      PMCID： PMC1125122          DOI： 10.1136/bmj.326.7383.262

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  30 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 4.  Drosophila innate immunity: an evolutionary perspective.

Authors:  Jules A Hoffmann; Jean-Marc Reichhart
Journal:  Nat Immunol       Date:  2002-02       Impact factor: 25.606

Review 5.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 6.  Toll-like receptors as adjuvant receptors.

Authors:  Tsuneyasu Kaisho; Shizuo Akira
Journal:  Biochim Biophys Acta       Date:  2002-02-13

Review 7.  Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.

Authors:  Jean-Louis Vincent; Qinghua Sun; Marc-Jacques Dubois
Journal:  Clin Infect Dis       Date:  2002-03-12       Impact factor: 9.079

8.  MIF regulates innate immune responses through modulation of Toll-like receptor 4.

Authors:  T Roger; J David; M P Glauser; T Calandra
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 9.  Pathogenesis of septic shock: implications for prevention and treatment.

Authors:  T Calandra
Journal:  J Chemother       Date:  2001-11       Impact factor: 1.714

10.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution.

Authors:  Yoshinori Nagai; Sachiko Akashi; Masakazu Nagafuku; Masato Ogata; Yoichiro Iwakura; Shizuo Akira; Toshio Kitamura; Atsushi Kosugi; Masao Kimoto; Kensuke Miyake
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606
View more
  38 in total

1.  Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Nieves Varela; Gema Robledo; Mario Delgado
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

3.  Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.

Authors:  Seung Hyun Han; Je Hak Kim; Ho Seong Seo; Michael H Martin; Gook-Hyun Chung; Suzanne M Michalek; Moon H Nahm
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 4.  [Sepsis. Update on pathophysiology, diagnostics and therapy].

Authors:  M Bauer; F Brunkhorst; T Welte; H Gerlach; K Reinhart
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

5.  Enhanced survival from CLP-induced sepsis following late administration of low doses of anti-IFNγ F(ab')2 antibody fragments.

Authors:  R Márquez-Velasco; A X Martínez-Velázquez; L M Amezcua-Guerra; F Flores-Guzmán; A Díaz-Quiñonez; F Massó; J Paniagua-Solís; R Bojalil
Journal:  Inflamm Res       Date:  2011-07-02       Impact factor: 4.575

6.  Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.

Authors:  Andrea Giacometti; Oscar Cirioni; Roberto Ghiselli; Federico Mocchegiani; Fiorenza Orlando; Carmela Silvestri; Argante Bozzi; Antonio Di Giulio; Carla Luzi; Maria Luisa Mangoni; Donatella Barra; Vittorio Saba; Giorgio Scalise; Andrea C Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  In vitro bactericidal effect of Ho:YAG laser and pneumatic lithotripsy on ureteral stones colonized with Escherichia coli and Enterococcus faecalis.

Authors:  Unsal Savci; Mustafa Sungur; Mustafa Sahin; Baris Eser; Selahattin Caliskan
Journal:  Urolithiasis       Date:  2019-03-20       Impact factor: 3.436

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Chemical modulators of the innate immune response alter gypsy moth larval susceptibility to Bacillus thuringiensis.

Authors:  Nichole A Broderick; Kenneth F Raffa; Jo Handelsman
Journal:  BMC Microbiol       Date:  2010-04-27       Impact factor: 3.605

10.  Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.

Authors:  Guangxun Meng; Mark Rutz; Matthias Schiemann; Jochen Metzger; Alina Grabiec; Ralf Schwandner; Peter B Luppa; Frank Ebel; Dirk H Busch; Stefan Bauer; Hermann Wagner; Carsten J Kirschning
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.